Lee C. Should Intravenous Fluids Be Administered During Hospitalizations for Sickle-Cell Disease?
NEJM EVIDENCE 2022;
1:EVIDtt2200159. [PMID:
38319834 DOI:
10.1056/evidtt2200159]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
Intravenous Fluids for Sickle-Cell DiseaseA 30-year-old woman with sickle-cell disease presents with diffuse pain in her arms, legs, and back. She has had frequent vaso-occlusive episodes, and this episode feels similar to previous ones. She is admitted for treatment, including with intravenous pain medications. Should she also receive intravenous fluids?
Collapse